Redefining the approach to CNS injury and neurodegenerative disorders

Developing a new class of non-cellular biologics, with an initial focus in stroke

 
aruna-main-graphic-2-CENTERED.jpg
 

Harnessing the power of neural exosomes

We are the experts in the design, loading and scaling of neural-derived exosomes, developing a new class of cell-free biologics and cell-mediated drug delivery systems to treat CNS and neurodegenerative disorders.

Through our lead program in stroke, we have demonstrated the unique ability of exosomes to enhance the nervous system’s self-repair mechanisms, leading to both structural and functional benefits in multiple preclinical models. To date, our exosomes have demonstrated:

 
brain.png
inflame.png
dosing.png
 
 

Learn more about the therapeutic potential of ArunA’s exosomes and our programs

 
iStock-547036698-[Converted]-muted.jpg
 

Empowering partners in delivering drugs to the CNS

Unrivaled uniformity, scalability and flexibility in manufacturing. Learn more about partnering with ArunA to build next generation therapeutics.

 
 
normal-forest.jpg
 

Subscribe

Want to keep informed with the latest developments from ArunA? Subscribe to our mailing list and you'll be the first to know. 

Name *
Name
 
aruna-main-graphic-2B_Footer.jpg